Improved Local Control following Dose-Escalated Stereotactic Ablative Radiation Therapy (SABR) for Metastatic Sarcomas: An International Multi-Institutional Experience

Over 90% of cancer related deaths are attributable to metastases, making early disease management – before distant progression occurs – critically important. [1] While relatively rare (approximately 1% of all cancers), sarcomas account for a disproportionate number of distant metastases when compared to other cancers. Inevitably, these metastases – which typically arise in the lungs and bo ne – lead to significant morbidity. Half of sarcoma patients will experience disease progression and their unfortunate sequelae: dyspnea, hemoptysis, bone fracture, and cord compression.

Source: Radiotherapy and Oncology - November 23, 2023 Category: Radiology Authors: Raj Singh, Alec Konrad, John G. Roubil, Jan Jenkins, Joanne Davis, John Austin Vargo, Emile Gogineni, Sanjeev Sharma Tags: Original Article Source Type: research